OpenURL Connection Search

Select item for more details and to access through your institution.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Published in:
European Journal of Neurology, 2014, v. 21, n. 1, p. 40, doi. 10.1111/ene.12204
By:
- Outteryck, O.;
- Ongagna, J.C.;
- Brochet, B.;
- Rumbach, L.;
- Lebrun‐Frenay, C.;
- Debouverie, M.;
- Zéphir, H.;
- Ouallet, J.C.;
- Berger, E.;
- Cohen, M.;
- Pittion, S.;
- Laplaud, D.;
- Wiertlewski, S.;
- Cabre, P.;
- Pelletier, J.;
- Rico, A.;
- Defer, G.;
- Derache, N.;
- Camu, W.;
- Thouvenot, E.
Publication type:
Article
Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica.
Published in:
European Journal of Neurology, 2011, v. 18, n. 6, p. 836, doi. 10.1111/j.1468-1331.2010.03252.x
By:
- Chanson, J.-B.;
- Zéphir, H.;
- Collongues, N.;
- Outteryck, O.;
- Blanc, F.;
- Fleury, M.;
- Vermersch, P.;
- de Seze, J.
Publication type:
Article
Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
Published in:
Multiple Sclerosis (13524585), 2007, v. 13, n. 5, p. 622, doi. 10.1177/1352458506071767
By:
- de Seze, J.;
- Debouverie, M.;
- Waucquier, N.;
- Steinmetz, G.;
- Pittion, S.;
- Zephir, H.;
- Fleury, M.;
- Blanc, F.;
- Vermersch, P.
Publication type:
Article
One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.
Published in:
Multiple Sclerosis (13524585), 2005, v. 11, n. 3, p. 360, doi. 10.1191/1352458505ms1172sr
By:
- Zéphir, H.;
- de Seze, J.;
- Dujardin, K.;
- Dubois, G.;
- Cabaret, M.;
- Bouillaguet, S.;
- Ferriby, D.;
- Stojkovic, T.;
- Vermersch, P.
Publication type:
Article
Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss.
Published in:
Multiple Sclerosis Journal, 2016, v. 22, n. 5, p. 649, doi. 10.1177/1352458515598021
By:
- Hadhoum, N.;
- Hodel, J.;
- Defoort-Dhellemmes, S.;
- Duhamel, A.;
- Drumez, E.;
- Zéphir, H.;
- Pruvo, J. P.;
- Leclerc, X.;
- Vermersch, P.;
- Outteryck, O.
Publication type:
Article
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Published in:
Multiple Sclerosis Journal, 2014, v. 20, n. 8, p. 1086, doi. 10.1177/1352458513515085
By:
- Collongues, N;
- Marignier, R;
- Jacob, A;
- Leite, MI;
- Siva, A;
- Paul, F;
- Zephir, H;
- Akman-Demir, G;
- Elsone, L;
- Jarius, S;
- Papeix, C;
- Mutch, K;
- Saip, S;
- Wildemann, B;
- Kitley, J;
- Karabudak, R;
- Aktas, O;
- Kuscu, D;
- Altintas, A;
- Palace, J
Publication type:
Article
Longitudinal follow-up of vision in a neuromyelitis optica cohort.
Published in:
Multiple Sclerosis Journal, 2013, v. 19, n. 10, p. 1320, doi. 10.1177/1352458513476562
By:
- Bouyon, M;
- Collongues, N;
- Zéphir, H;
- Ballonzoli, L;
- Jeanjean, L;
- Lebrun, C;
- Chanson, JB;
- Blanc, F;
- Fleury, M;
- Outteryck, O;
- Defoort, S;
- Labauge, P;
- Vermersch, P;
- Speeg, C;
- De Seze, J
Publication type:
Article
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2012, v. 18, n. 1, p. 55, doi. 10.1177/1352458511416839
By:
- Le Bouc, R;
- Zéphir, H;
- Majed, B;
- Vérier, A;
- Marcel, M;
- Vermersch, P
Publication type:
Article
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
Published in:
Multiple Sclerosis Journal, 2011, v. 17, n. 6, p. 720, doi. 10.1177/1352458510396923
By:
- Collongues, N.;
- Marignier, R.;
- Zéphir, H.;
- Blanc, F.;
- Vukusic, S.;
- Outteryck, O.;
- Fleury, M.;
- Ruet, A.;
- Borgel, F.;
- Thouvenot, E.;
- Moreau, T.;
- Defer, G.;
- Derache, N.;
- Pelletier, J.;
- Audoin, B.;
- Debouverie, M.;
- Labauge, P.;
- Gout, O.;
- Camu, W.;
- Brassat, D.
Publication type:
Article
Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice.
Published in:
Journal of Neurology, 2010, v. 257, n. 2, p. 207, doi. 10.1007/s00415-009-5294-0
By:
- Outteryck, Olivier;
- Ongagna, J.-C.;
- Zéphir, H.;
- Fleury, M.-C.;
- Lacour, A.;
- Blanc, F.;
- Vermersch, P.;
- de Sèze, J.
Publication type:
Article
Long-term outcome of acute and subacute myelopathies.
Published in:
Journal of Neurology, 2009, v. 256, n. 6, p. 980, doi. 10.1007/s00415-009-5058-x
By:
- Debette, S.;
- de Sèze, J.;
- Pruvo, J.-P.;
- Zephir, H.;
- Pasquier, F.;
- Leys, D.;
- Vermersch, P.
Publication type:
Article
Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis.
Published in:
Journal of Neurology, 2012, v. 259, n. 6, p. 1215, doi. 10.1007/s00415-011-6339-8
By:
- Melin, A.;
- Outteryck, O.;
- Collongues, N.;
- Zéphir, H.;
- Fleury, M.;
- Blanc, F.;
- Lacour, A.;
- Ongagna, J.;
- Berteloot, A.;
- Vermersch, P.;
- Sèze, J.
Publication type:
Article
Is neuromyelitis optica associated with human leukocyte antigen?
Published in:
Multiple Sclerosis (13524585), 2009, v. 15, n. 5, p. 571
By:
- Zéphir, H.;
- Fajardy, I.;
- Outteryck, O.;
- Blanc, F.;
- Roger, N.;
- Fleury, M.;
- Rudolf, G.;
- Marignier, R.;
- Vukusic, S.;
- Confavreux, C.;
- Vermersch, P.;
- de Seze, J.
Publication type:
Article
Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis.
Published in:
Multiple Sclerosis (13524585), 2009, v. 15, n. 5, p. 593
By:
- Zéphir, H.;
- Lefranc, D.;
- Dubucquoi, S.;
- de Seze, J.;
- Boron, L.;
- Prin, L.;
- Vermersch, P.
Publication type:
Article
High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.
Published in:
British Journal of Pharmacology, 2015, v. 172, n. 7, p. 1769, doi. 10.1111/bph.13037
By:
- Oxombre, B;
- Lee ‐ Chang, C;
- Duhamel, A;
- Toussaint, M;
- Giroux, M;
- Donnier ‐ Maréchal, M;
- Carato, P;
- Lefranc, D;
- Zéphir, H;
- Prin, L;
- Melnyk, P;
- Vermersch, P
Publication type:
Article
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
Published in:
2022
By:
- Lefort, M.;
- Sharmin, S.;
- Andersen, J. B.;
- Vukusic, S.;
- Casey, R.;
- Debouverie, M.;
- Edan, G.;
- Ciron, J.;
- Ruet, A.;
- De Sèze, J.;
- Maillart, E.;
- Zephir, H.;
- Labauge, P.;
- Defer, G.;
- Lebrun-Frenay, C.;
- Moreau, T.;
- Berger, E.;
- Clavelou, P.;
- Pelletier, J.;
- Stankoff, B.
Publication type:
journal article

Found: 16